Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment

被引:42
作者
Smith, R
Malee, K
Charurat, M
Magder, L
Mellins, C
MacMillan, C
Hittleman, J
Lasky, T
Llorente, A
Moye, J
机构
[1] Univ Illinois, Chicago, IL 60612 USA
[2] Northwestern Univ, Childrens Mem Hosp, Chicago, IL 60614 USA
[3] Inst Human Virol, Baltimore, MD USA
[4] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[5] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] NICHHD, NIH, Bethesda, MD 20892 USA
关键词
pediatric human immunodeficiency virus type 1; infection; developmental outcome; early vs. late infant infection;
D O I
10.1097/00006454-200009000-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Identifying HIV-1-infected children who are at greatest risk for disease-related morbidities is critical for optimal therapeutic as well as preventive care. Several factors have been implicated in HIV-1 disease onset and severity, including maternal and infant host characteristics, viral phenotype and timing of HIV-1 infection. Early HIV-1 culture positivity, i.e. intrauterine infection, has been associated with poor immunologic, virologic and clinical outcomes in children of HIV-infected women. However, a direct effect of timing of infection on neurodevelopmental outcome in infancy has not yet been identified. Methods. Serial neurodevelopmental assessments were performed with 114 infants vertically infected with HIV-1 in a multicenter natural history, longitudinal study. Median mental and motor scores were compared at three time points. Longitudinal regression analyses were used to evaluate the neurodevelopmental functioning of children with early positive cultures and those with late positive cultures. Results. Early infected infants scored significantly lower than late infected infants by 24 months of age and beyond on both mental (P = 0.05) and motor (P = 0.03) measures. Early HIV-1 infection was associated with a decline in estimated motor scores of 1 standard score point per month compared with 0.28 point in the late infected group (P < 0.02). Estimated mental. scores of the early infected group declined 0.72 point/month, whereas the average decline of the late infected group was 0.30 point/month (P < 0.13). Conclusion. Early HIV-1 infection increases a child's risk for poor neurodevelopmental functioning within the first 30 months of life.
引用
收藏
页码:862 / 871
页数:10
相关论文
共 45 条
[1]  
[Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1
[2]  
Bayley N., 1969, BAYLEY SCALES INFANT
[3]   RELATION OF THE COURSE OF HIV-INFECTION IN CHILDREN TO THE SEVERITY OF THE DISEASE IN THEIR MOTHERS AT DELIVERY [J].
BLANCHE, S ;
MAYAUX, MJ ;
ROUZIOUX, C ;
TEGLAS, JP ;
FIRTION, G ;
MONPOUX, F ;
CIRARUVIGNERON, N ;
MEIER, F ;
TRICOIRE, J ;
COURPOTIN, C ;
VILMER, E ;
GRISCELLI, C ;
DELFRAISSY, JF ;
TARDIEU, M ;
NOSEDA, G ;
HURAUX, JM ;
LEVINE, M ;
VILMER, E ;
DECREPY, A ;
SIMON, F ;
KRIVINE, A ;
FRANCOUAL, C ;
DIMARIA, L ;
COURPOTIN, C ;
MONCOMBLE, CC ;
BURGARD, M ;
ROUZIOUX, C ;
GIRAULT, D ;
STEPHAN, JL ;
BLANCHE, S ;
TERRIS, J ;
VEBER, F ;
FIRTION, G ;
HENRION, R ;
CIRARUVIGNERON, N ;
BRUNER, C ;
MATHIEU, FP ;
HERVE, F ;
ALLISY, C ;
DANDINE, M ;
LABRUNE, P ;
VIAL, M ;
LACHASSINE, E ;
GAUDELUS, J ;
FLOCH, C ;
MAZY, F ;
MEIER, F ;
ROBIN, M ;
ALLEMON, MC ;
TALON, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (05) :308-312
[4]   Morbidity and mortality in European children vertically infected by HIV-1 - The French pediatric HIV infection study group and European collaborative study [J].
Blanche, S ;
Newell, ML ;
Mayaux, MJ ;
Dunn, DT ;
Teglas, JP ;
Rouzioux, C ;
Peckham, CS .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 14 (05) :442-450
[5]   LONGITUDINAL-STUDY OF 94 SYMPTOMATIC INFANTS WITH PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - EVIDENCE FOR A BIMODAL EXPRESSION OF CLINICAL AND BIOLOGICAL SYMPTOMS [J].
BLANCHE, S ;
TARDIEU, M ;
DULIEGE, AM ;
ROUZIOUX, C ;
LEDEIST, F ;
FUKUNAGA, K ;
CANIGLIA, M ;
JACOMET, C ;
MESSIAH, A ;
GRISCELLI, C .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (11) :1210-1215
[6]   EFFECT OF CONTINUOUS-INFUSION ZIDOVUDINE THERAPY ON NEUROPSYCHOLOGICAL FUNCTIONING IN CHILDREN WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BROUWERS, P ;
MOSS, H ;
WOLTERS, P ;
EDDY, J ;
BALIS, F ;
POPLACK, DG ;
PIZZO, PA .
JOURNAL OF PEDIATRICS, 1990, 117 (06) :980-985
[7]  
BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718
[8]   GUIDELINE FOR FLOW CYTOMETRIC IMMUNOPHENOTYPING - A REPORT FROM THE NATIONAL-INSTITUTE-OF-ALLERGY-AND-INFECTIOUS-DISEASES, DIVISION OF AIDS [J].
CALVELLI, T ;
DENNY, TN ;
PAXTON, H ;
GELMAN, R ;
KAGAN, J .
CYTOMETRY, 1993, 14 (07) :702-715
[9]  
CHASE C, IN PRESS PEDIATRICS
[10]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180